Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

Advances in Rare Cardiovascular Disease

UCL Personalised Medicine Domain

Friday, July 1, 2016 from 9:00 AM to 6:15 PM (BST)

Ticket Information

Type End Quantity
Advances in Rare Cardiovascular Disease   more info Ended Free  

Share Advances in Rare Cardiovascular Disease

Event Details

UCL Populations & Lifelong Health Domain

Advances in Rare Cardiovascular Disease Symposium

Friday 1 July 2016 


Tickets for the Advances in Rare Cardiovascular Disease Symposium have now sold out.

However, please add your details to the waiting list and if a ticket becomes available you will be contacted automatically with further instructions on how to book your ticket.

If you are not contacted before the event about newly available tickets, it may still be worth coming to the venue on the day, as you may be able to gain entrance to the event if there are people who do not show up. Whilst it is likely that there will be 'no shows', there is obviously no way of us knowing for sure, so we are not able guarantee you admittance on the day.



There are between 6,000 and 8,000 known rare disorders and it is estimated that a rare disease will affect 1 in 17 of the European population at some point in their lives. Many of these disorders primarily affect the cardiovascular system or, as in the case of rare metabolic and neurological conditions, are characterised by cardiovascular involvement that is the major determinant of prognosis and quality of life.

In this second joint meeting between UCL, Queen Mary University of London and Barts Health NHS Trust, we bring together globally recognised experts in a one-day symposium designed to showcase translational research in rare cardiovascular disease and to catalyse interaction between scientists, clinicians and patient representatives.

The key themes are:

  • Cardiomyopathy
  • Inherited Arrhythmia Syndromes
  • Myocardial Inflammation
  • Cardiac Involvement in Systemic Disorders

The symposium promises to be a fascinating day with a mixture of insightful talks and time to network with your peers and colleagues.

Let us know you’ve reserved your place or tell us what you’re most looking forward to seeing at the event by tweeting us @UCL_SLMS using the hashtag #RareCardioDiseaseSym



Final programme:

8.30-9.00    Registration

9.00-9.10    Welcome

Professor Graham J Hart (Dean of the UCL Faculty of Population Health Sciences)

9.10-10.35    Session one: Inherited cardiomyopathies

Chairs: Professor Iacopo Olivotto (Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy) and Professor Aleš Linhart (2nd Department of Internal Cardiovascular Medicine, General University Hospital in Prague, Charles University in Prague, First Medical Faculty)


Professor Luisa Mestroni (University of Colorado Anschutz Medical Campus, and Heart Failure and Advanced Therapies Clinic, Division of Cardiology, University of Colorado Hospital)
Novel genetic models for arrhythmogenic right ventricular cardiomyopathy

Dr Caroline Coats (UCL Institute of Cardiovascular Science)
- Biomarkers in hypertrophic cardiomyopathy

Professor Maria Carmo-Fonseca (Institute of Molecular Medicine, University of Lisbon)
- Non-coding variants in cardiomyopathies

Keynote: Professor Mathias Gautel (Cardiovascular Division and The Randall Division of Cell and Molecular Biophysics, King's College London)
- Titin in health and disease

10.35-11.00    Networking break

11.00-12.25    Session two: Inherited arrhythmia syndromes

Chairs: Professor Christopher Huang (Physiological Laboratory, University of Cambridge) and Professor Perry Elliott (UCL Institute of Cardiovascular Science and Barts Heart Centre)

Professor Andrew Tinker (William Harvey Heart Centre, Queen Mary University of London)
- Cellular models of ion channel disease

Professor Pier Lambiase (UCL Institute of Cardiovascular Science and Barts Heart Centre)
- Non-invasive substrate imaging of arrhythmia syndromes

Professor Peter Taggart (UCL Institute of Cardiovascular Science)
- Dissecting the molecular basis of electrical alternans

Keynote: Professor Dr Arthur AM Wilde (Heart Centre Academic Medical Centre, University of Amsterdam Medical Centre)
- Translating molecular discoveries into clinical practice

12.25-1.25    Lunch

1.25-2.50    Session three: Myocardial inflammation

Chair: Professor Eloisa Arbustini (Centre for Inherited Cardiovascular Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy)

Professor Perry Elliott (UCL Institute of Cardiovascular Science and Barts Heart Centre)
- Implications of ESC Guidelines on myocarditis for translational research and clinical practice

Dr Leon Menezes (University College Hospital)
- Role of CMR and nuclear imaging in the diagnosis of myocarditis

Professor Federica Marelli-Berg (Centre for Biochemical Pharmacology, Heart Centre, William Harvey Research Institute, Queen Mary University of London)
- Heart-selective immunosuppression

Keynote: Professor Heinz-Peter Schultheiß (Freie Universität Berlin)
Controversies and future directions in the diagnosis and treatment of myocarditis

2.50-3.10    Networking break

3.10-4.15    Session four: The heart in systemic disease

Chairs: Dr Robin Lachmann (Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery) and Professor Panagiotis Deloukas (William Harvey Research Institute, Queen Mary University of London)

Dr Juan Pablo Kaski (Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital (GOSH) and UCL Institute of Cardiovascular Science)

- The RAS-MAPK system and myocardial disease

Dr Elaine Murphy (Charles Dent Metabolic Unit, National Hospital for Neurology and Neurosurgery)
- Polyglucosan body disease and the heart

Keynote: Dr Derralynn Hughes (Lysosomal Storage Disorders Unit, Royal Free London NHS Trust and UCL)
- Perspectives on the treatment of Anderson Fabry Disease

4.15-4.25    Comfort break

4.25-5.10    Session five: Discoveries from the clinics

Chair: Professor Aroon Hingorani (UCL Institute of Cardiovascular Science and UCL Hospitals NHS Foundation Trust) and Professor Mark Caulfield (Queen Mary University of London)

Dr Luis Lopes (Cardiovascular Centre, University of Lisbon - Faculty of Medicine; Hospital Garcia de Orta, Portugal; and UCL Institute of Cardiovascular Science) and Dr Andrea Ghisleni (King's College London)
- A stiff heart

Dr Elaine Murphy (National Hospital for Neurology and Neurosurgery) and Dr Oliver Watkinson (UCL Institute of Cardiovascular Science)
- A needle in the haystack

Professor Pier Lambiase (UCL Institute of Cardiovascular Science and Barts Heart Centre) and Dr Stephen Harmer (Queen Mary University of London)
- More than just a long QT interval

5.10-5.15    Closing remarks

5.15-6.15    Networking drinks reception



Who should attend?

This meeting is open to all researchers (PhD students, postdocs, research associates and Principal Investigators) and clinicians working on any aspect of cardiovascular science within UCLPartners.

To confirm authenticity of your registration, please use your UCL/NHS/academic email address when registering (i.e. do not use gmail, hotmail etc).



QMUL/UCL Joint Cardiovascular Institute

QMUL and UCL have established a joint Cardiovascular Institute to rise to the global challenge of cardiovascular disease. The endeavour will provide support for the UCLPartners cardiovascular Academic Medical Centre, the hub of which will be the new Barts Heart Centre. By combining joint strengths in discovery science, experimental medicine, therapeutic innovation and population health sciences, and our involvement with The Francis Crick Institute, National Institute for Cardiovascular Outcomes Research, the Farr Institute and Genomics England, the Institute will drive forward diagnostic and therapeutic innovation and prevention strategies to address the extensive burden of cardiovascular disease in North Central and East London. 




The Advances in Rare Cardiovascular Disease Symposium is supported by an unrestricted educational grant from the following organisation, for which we are very grateful:



This event is being organised in partnership with:


Instructions for logging back into Eventbrite:

1. Go to (please note, do not try to log into Eventbrite using the symposium registration link)

2. Click on the log in button (if you have an account you will need to enter your password, if not you will need to ask Eventbrite to email you a new password).

3. When you get into your account, click on My Tickets, find the symposium ticket and then click on Manage Order.

Please note: There will be photographs taken during the symposium. In registering for this symposium you are agreeing that your image may be used in future UCL promotional material. 





The personal details that you provide to receive communications from us will be processed by Eventbrite, a third party provider, on behalf of UCL and will be stored securely on servers owned by Eventbrite located in the United States.  Further information on Eventbrite’s privacy policy can be found here. UCL will remain responsible for your personal data as data controller and all queries should be directed to By continuing you are agreeing to this processing.



Have questions about Advances in Rare Cardiovascular Disease? Contact UCL Personalised Medicine Domain

When & Where

UCL Main Quad Pavilion
Gower Street
WC1E 6BT London
United Kingdom

Friday, July 1, 2016 from 9:00 AM to 6:15 PM (BST)

  Add to my calendar


UCL Personalised Medicine Domain

The Symposium is supported by the UCL Personalised Medicine Domain, which harnesses the breadth and depth of the personalised medicine research activity taking place across UCL and its partner hospitals, supporting the delivery of innovative patient-targeted medicines and therapies.


  Contact the Organizer

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.